56
Participants
Start Date
September 19, 2022
Primary Completion Date
August 9, 2024
Study Completion Date
January 17, 2025
DONQ52
Subcutaneous (SC) injection
Placebo
Subcutaneous (SC) injection
Campbelltown Hospital, Campbelltown
University of Sunshine Coast Clinical Trials Centre - Morayfield, Morayfield
Linear Clinical Research, Nedlands
Columbia University Medical Center, New York
Long Island Gastrointestinal Research Group, Great Neck
North Carolina Clinical Research, Raleigh
Lucas Research - Diabetes & Endocrinology Consultants, PC, Morehead City
Velocity Clinical Research, Anderson, Anderson
Jacksonville Center for Clinical Research, Jacksonville
Clinical Site Partners - Orlando, Winter Park
Clinical Site Partners, Leesburg
Pinnacle Research Group, Anniston
Alliance for Multispecialty Research, Knoxville
Aventiv Research, Inc., Columbus
Digestive Specialists Inc, Dayton
Mayo Clinic - Rochester, Rochester
Tandem Clinical Research, Marrero
Digestive Research of Central Texas, Waco
Mountain View Clinical Research, Denver
Velocity Clinical Research - Boise, Meridian
Care Access Research, Ogden
Lead Sponsor
Chugai Pharmaceutical
INDUSTRY